Home › NDC Lookup › RxCUI directory › RxCUI 2716578

Capsaicin 0.5 MG/ML / menthol 20 MG/ML Topical Cream — RxCUI 2716578

RxNorm drug concept · Semantic clinical drug
RxCUI 2716578 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2716578
Official nameCapsaicin 0.5 MG/ML / menthol 20 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascapsaicin 0.05 % / menthol 2 % Topical Cream
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Capsaicin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, that burning or warming feeling is expected and is actually part of how it works. Capsaicin activates the same heat-sensing nerve endings that cause pain, so you feel that war...
  • Why does capsaicin make my skin burn — is that normal?
  • Please don't — that combination can cause serious burns. Heat sources like heating pads or hot water bottles significantly increase the risk when used alongside capsaicin. For the...
  • Can I put a heating pad on after applying it to help with the pain more?
📖 Read our full Capsaicin Topical guide →

🕸️ Concept Web — How Capsaicin 0.5 MG/ML / menthol 20 MG/ML Topical C... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Capsaicin 0.5 MG/ML / menthol 20 MG/ML Topical Cream RxCUI 2716578

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Capsaicin 1992
    • Menthol 6750
    • Capsaicin / menthol 1007122
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Capsaicin / menthol Topical Cream 379012
    • Capsaicin / menthol Topical Product 1155436
    • Topical Cream 316982
    • Topical Product 1151122
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Capsaicin 0.5 MG/ML 358529
    • Menthol 20 MG/ML 384559

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Capsaicin 0.5 MG/ML SCDC · 358529
  • Menthol 20 MG/ML SCDC · 384559
  • Capsaicin / menthol Topical Cream SCDF · 379012
  • Capsaicin / menthol Topical Product SCDG · 1155436

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2716578 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59088-0794-05 57 g in 1 TUBE (59088-794-05) Diabecin CS Cream Puretek Corporation 2025-06-10
Observed labelers: Puretek Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.